Chongqing Lummy Pharmaceutical (300006)

Shenzhen
Currency in CNY
3.86
-0.02(-0.52%)
Closed

300006 Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2023
01/01
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,859.011,583.531,225.22884.59895.59
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+18.99%-14.82%-22.63%-27.8%+1.24%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa542.86526.96380.93238.66283.15
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa1,316.151,056.57844.3645.93612.44
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+39.72%-19.72%-20.09%-23.5%-5.19%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa70.8%66.72%68.91%73.02%68.38%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1,306.791,171.75977.73751.82669.15
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+58.4%-10.33%-16.56%-23.11%-11%
aa.aaaa.aaaa.aaaa.aaaa.aa164.04107.36100.280.6599.81
aa.aaaa.aaaa.aaaa.aaaa.aa1,112.691,039.03852.82654595
aa.aaaa.aaaa.aaaa.aaaa.aa30.0625.3624.717.18-25.67
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa9.36-115.18-133.43-105.89-56.71
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-92%-1,330.29%-15.84%+20.64%+46.45%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa0.5%-7.27%-10.89%-11.97%-6.33%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-68-73.4529.37-1.64109.18
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-188.23%-8.02%+139.99%-105.58%+6,765.57%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-72.33-83.19-32.08-20.35-12.47
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa4.349.7461.4518.71121.66
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-6.53-24.22-25.89-42.66-4.92
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-65.16-212.85-129.95-150.1947.56
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa0.340.65-0.030.260.45
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa51.12-46.3924.0174.68-43.13
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-169.72-343.6-105.96-75.253.59
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-255.27%-102.45%+69.16%+28.99%+104.78%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-9.13%-21.7%-8.65%-8.51%0.4%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa-8.331.05-0.031.0413.61
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-161.39-344.66-105.94-76.28-10.02
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa6.1917.895.417.581.09
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-155.2-326.76-100.53-68.71-8.93
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-258.36%-110.55%+69.24%+31.66%+87.01%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-8.35%-20.64%-8.2%-7.77%-1%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-155.2-326.76-100.53-68.71-8.93
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-0.19-0.4-0.1-0.07-0.01
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-258.33%-110.52%+74.89%+35.54%+86.94%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-0.19-0.4-0.1-0.07-0.01
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-258.33%-110.52%+74.89%+35.54%+86.94%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa812.13812.24995.331,055.381,050.27
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa812.13812.24995.331,055.381,050.27
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa0.05----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa0%----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa117.87-6.4-63.41-35.297.43
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-47.49%-105.43%-891.37%+44.35%+121.05%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aa